Federal inspectors found “deficient practices” at a Theranos Inc. laboratory that “pose immediate jeopardy to patient health and safety,” according a letter released Wednesday.

The Centers for Medicare and Medicaid Services said an inspection completed in November at the company’s lab in Newark, Calif., uncovered five major infractions that violate the federal law governing clinical labs.

The...